These Bond ETFs Are Still Winning Amid Trump Tariff Selloff


In the wake of President Donald Trump's recent tariff implementations, financial markets have experienced significant volatility. While equities have faced sharp declines, certain bond Exchange-Traded Funds (ETFs) have demonstrated resilience, offering investors a safe haven amid the turbulence.​

Treasury Bond ETFs: A Safe Harbor

As fears of an economic slowdown intensify due to escalating trade tensions, investors are increasingly turning to U.S. Treasury bonds, traditionally viewed as low-risk assets. This shift has led to notable gains in several Treasury-focused ETFs:​

  • iShares 20+ Year Treasury Bond ETF (TLT): This ETF, which tracks long-term U.S. Treasury bonds, has seen a 1.5% increase over the past month. ​

  • iShares 25+ Year Treasury STRIPS Bond ETF (GOVZ): Offering exposure to U.S. principal STRIPS with maturities of at least 25 years, GOVZ has experienced a 3% uptick. ​

  • PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF (ZROZ): Focusing on the long end of the yield curve, ZROZ has risen by 2.8%. ​

These ETFs have benefited from declining yields, as bond prices and yields move inversely. The 10-year Treasury yield has dropped to its lowest level since December, reflecting increased demand for these securities. ​

Market Dynamics and Investor Sentiment

The imposition of tariffs has heightened concerns over a potential economic slowdown, prompting investors to seek refuge in safer assets. This flight to quality has bolstered Treasury ETFs, even as equity markets have suffered. Additionally, the Federal Reserve's recent decision to hold interest rates steady has influenced bond market dynamics, contributing to the observed trends in these ETFs. ​

Conclusion

Amid the market volatility spurred by President Trump's tariff policies, certain bond ETFs, particularly those focused on long-term U.S. Treasury securities, have emerged as resilient performers. Investors seeking stability during these uncertain times may find these ETFs to be viable options for preserving capital and mitigating risk.

Comments

Post a Comment

Popular posts from this blog

3 Big Energy Stocks Offering Strong Dividends Amid Volatility

Image
3 Big Energy Stocks Offering Strong Dividends Amid Volatility By Steven Orlowski, CFP, CNPR In a market marked by persistent uncertainty, rising interest rates, and geopolitical tensions, income investors are seeking stability and yield in all the right places. One sector continues to stand out: energy. While oil and gas prices remain volatile, the long-term demand outlook and disciplined capital strategies have turned several major energy companies into dividend powerhouses. Here are three energy giants offering robust dividend yields and resilient fundamentals, making them attractive options for investors seeking income and relative stability in turbulent times. 1. ExxonMobil (NYSE: XOM) Dividend Yield: ~3.4% Market Cap: $470+ billion ExxonMobil is one of the largest integrated oil and gas companies in the world. Its scale, upstream and downstream operations, and global reach offer a level of diversification that helps buffer against short-term price swings. In recent year...
Read more

Stocks making the biggest moves midday: Eli Lilly, Alphabet, Hertz, UnitedHealth and more

Image
  Stocks Making the Biggest Moves Midday: Eli Lilly, Alphabet, Hertz, UnitedHealth, and More ​ As of midday on Thursday, April 17, 2025, U.S. stock markets exhibited mixed performance, with significant movements in several key stocks. The Dow Jones Industrial Average dropped nearly 400 points, primarily due to a sharp decline in UnitedHealth Group shares. Conversely, the S&P 500 and Nasdaq Composite showed modest gains. ​ Eli Lilly (LLY) – Soaring on Weight-Loss Pill Success Eli Lilly's stock surged by up to 17% following the announcement of successful phase-three trial results for its new weight-loss pill, orforglipron. This once-daily oral medication demonstrated effectiveness comparable to injectable alternatives like Novo Nordisk's Ozempic, leading to an average weight loss of 16 pounds (about 8% of body weight) and a reduction in A1C levels by 1.3% to 1.6%. The promising results have investors optimistic about the drug's potential market impact. ​ United...
Read more

Stock Spotlight – Stock of the Week: UnitedHealth: Where Does the Company Stand After the Storm?

Image
  Stock Spotlight – Stock of the Week: UnitedHealth: Where Does the Company Stand After the Storm? UnitedHealth Group (NYSE: UNH), a cornerstone of the American healthcare industry, has weathered its share of challenges over the past year. From regulatory pressures and increased utilization costs to a rapidly evolving competitive landscape, investors have had plenty to digest. But as the dust settles, one question remains: Where does UnitedHealth stand now—and is it still a buy? A Quick Look Back: Navigating Headwinds 2024 was a turbulent year for UnitedHealth. The company faced mounting pressure from multiple fronts: Rising medical costs , particularly in its Medicare Advantage segment, dented margins. Regulatory scrutiny intensified, especially around pharmacy benefit management (PBM) practices and alleged anti-competitive behavior. The change in utilization patterns , with more seniors returning to in-person care post-pandemic, increased short-term claims expenses. ...
Read more